Stroke and diabetes mellitus

Handbook of Clinical Neurology

Volumn 126, Issue , 2014, Pages 167-174

  Hill, Michael D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Intracerebral hemorrhage; Ischemic stroke; Lacunar stroke; Small subcortical stroke; Subarachnoid hemorrhage; Venous sinus thrombosis

Indexed keywords

ANIMAL; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; MICROVASCULATURE; PATHOLOGY; RISK FACTOR; STROKE;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; MICROVESSELS; RISK FACTORS; STROKE;

EID: 84921974656     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53480-4.00012-6     Document Type: Chapter

References (40)

1. ACCORD Study Group, ACCORD Eye Study Group, Chew E.Y., et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010, 363:233-244.
2. ACCORD Study Group, Ginsberg H.N., Elam M.B., Lovato L.C., et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010, 362:1563-1574.
3. ACCORD Study Group, Cushman W.C., GW Evans, Byington R.P., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 362:1575-1585.
4. ACCORD Study Group, Gerstein H.C., Miller M.E., Genuth S., et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011, 364:818-828.
5. Agus M.S., Steil G.M., Wypij D., et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012, 367:1208-1219.
6. Allport L.E., Butcher K.S., Baird T.A., et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 2004, 35:1886-1891.
7. Amarenco P., Bogousslavsky J., Callahan A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559.
8. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
9. Bruno A., Levine S.R., Frankel M.R., et al. Admission glucose level and clinical outcomes in the NINDS RT-PA Stroke Trial. Neurology 2002, 59:669-674.
10. Bruno A., Kent T.A., Coull B.M., et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 2008, 39:384-389.
11. Chalmers J., Cooper M.E. UKPDS and the legacy effect. N Engl J Med 2008, 359:1618-1620.
12. Collins R., Armitage J., Parish S., Group Heart Protection Study Collaborative, et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004, 363:757-767.
13. De Keyzer K., Paemeleire K., De Clerck M., et al. Diabetic ketoacidosis presenting as a cerebral venous sinus thrombosis. Acta Neurol Belg 2004, 104:117-120.
14. Demchuk A.M., Morgenstern L.B., Krieger D.W., et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34-39.
15. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986.
16. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:331-337.
17. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
18. Field T.S., Green T.L., Roy K., et al. Trends in hospital admission for stroke in Calgary. Can J Neurol Sci 2004, 31:387-393.
19. Fisher C.M. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979, 36:65-73.
20. Furie K.L., Kasner S.E., Adams R.J., et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:227-276.
21. Goldstein L.B., Amarenco P., Szarek M., et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008, 70:2364-2370.
22. Gouw A.A., van der Flier W.M., Fazekas F., et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the leukoaraiosis and disability study. Stroke 2008, 39:1414-1420.
23. Gray C.S., Hildreth A.J., Sandercock P.A., et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007, 6:397-406.
24. Hagg S., Thorn L.M., Putaala J., et al. Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 2013, 36:4140-4146.
25. Jauch E.C., Saver J.L., Adams H.P., et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44:870-947.
26. Johnston K.C., Hall C.E., Kissela B.M., et al. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 2009, 40:3804-3809.
27. Keane S., Gallagher A., Ackroyd S., et al. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child 2002, 86:204-205.
28. Lindsay P., Bayley M., McDonald A., et al. Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care. CMAJ 2008, 178(11):1418-1425.
29. Martini S.R., Hill M.D., Alexandrov A.V., et al. Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy. Neurology 2006, 67:700-702.
30. Mohr J.P., Kase C.S., Meckler R.J., et al. Sensorimotor stroke due to thalamocapsular ischemia. Arch Neurol 1977, 34:739-741.
31. NICE-SUGAR Study Investigators, Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
32. Patel A., ADVANCE Collaborative Group, MacMahon S., et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007, 370:829-840.
33. Petitti D.B., Bhatt H. Retinopathy as a risk factor for nonembolic stroke in diabetic subjects. Stroke 1995, 26:593-596.
34. Pettersen J.A., Pexman J.H., Barber P.A., et al. Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3h of onset. J Neurol Neurosurg Psychiatry 2006, 77:885-887.
35. Poppe A.Y., Majumdar S.R., Jeerakathil T., et al. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009, 32:617-622.
36. Sasiadek M.J., Sosnowska-Pacuszko D., Zielinska M., et al. Cerebral venous thrombosis as a first presentation of diabetes. Pediatr Neurol 2006, 35:135-138.
37. Scott J.F., Robinson G.M., French J.M., et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999, 30:793-799.
38. Snowdon D.A., Greiner L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
39. SPS3 Investigators, Benavente O.R., Hart R.G., McClure L.A., et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012, 367:817-825.
40. SPS3 Study Group, Benavente O.R., Coffey C.S., Conwit R., et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013, 382:507-515.